Skip to main content
Top
Published in: Respiratory Research 1/2018

Open Access 01-12-2018 | Research

Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis

Authors: Kate M. Johnson, Stirling Bryan, Shahzad Ghanbarian, Don D. Sin, Mohsen Sadatsafavi

Published in: Respiratory Research | Issue 1/2018

Login to get access

Abstract

Background

A significant proportion of patients with chronic obstructive pulmonary disease (COPD) remain undiagnosed. Characterizing these patients can increase our understanding of the ‘hidden’ burden of COPD and the effectiveness of case detection interventions.

Methods

We conducted a systematic review and meta-analysis to compare patient and disease factors between patients with undiagnosed persistent airflow limitation and those with diagnosed COPD. We searched MEDLINE and EMBASE for observational studies of adult patients meeting accepted spirometric definitions of COPD. We extracted and pooled summary data on the proportion or mean of each risk factor among diagnosed and undiagnosed patients (unadjusted analysis), and coefficients for the adjusted association between risk factors and diagnosis status (adjusted analysis).

Results

Two thousand eighty-three records were identified through database searching and 16 articles were used in the meta-analyses. Diagnosed patients were less likely to have mild (v. moderate to very severe) COPD (odds ratio [OR] 0.30, 95%CI 0.24–0.37, 6 studies) in unadjusted analysis. This association remained significant but its strength was attenuated in the adjusted analysis (OR 0.72, 95%CI 0.58–0.89, 2 studies). Diagnosed patients were more likely to report respiratory symptoms such as wheezing (OR 3.51, 95%CI 2.19–5.63, 3 studies) and phlegm (OR 2.16, 95% CI 1.38–3.38, 3 studies), had more severe dyspnea (mean difference in modified Medical Research Council scale 0.52, 95%CI 0.40–0.64, 3 studies), and slightly greater smoking history than undiagnosed patients. Patient age, sex, current smoking status, and the presence of coughing were not associated with a previous diagnosis.

Conclusions

Undiagnosed patients had less severe airflow obstruction and fewer respiratory symptoms than diagnosed patients. The lower disease burden in undiagnosed patients may significantly delay the diagnosis of COPD.
Appendix
Available only for authorised users
Literature
1.
go back to reference From the Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: http://goldcopd.org. Cited 1 May 2017. From the Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: http://​goldcopd.​org. Cited 1 May 2017.
2.
go back to reference Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365:1184–92.CrossRefPubMed Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365:1184–92.CrossRefPubMed
3.
go back to reference Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodriguez E, Benet M, et al. Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation. BMC Pulm Med. 2015;15 Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodriguez E, Benet M, et al. Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation. BMC Pulm Med. 2015;15
4.
go back to reference Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–85.CrossRef Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–85.CrossRef
5.
go back to reference Haroon SM, Jordan RE, O’Beirne-Elliman J, Adab P. Effectiveness of case finding strategies for COPD in primary care: a systematic review and meta-analysis. NPJ Prim Care Respir Med. 2015;25:15056.CrossRefPubMedPubMedCentral Haroon SM, Jordan RE, O’Beirne-Elliman J, Adab P. Effectiveness of case finding strategies for COPD in primary care: a systematic review and meta-analysis. NPJ Prim Care Respir Med. 2015;25:15056.CrossRefPubMedPubMedCentral
6.
go back to reference Decramer M, Miravitlles M, Price D, Román-Rodríguez M, Llor C, Welte T, et al. New horizons in early stage COPD--improving knowledge, detection and treatment. Respir Med. 2011;105:1576–87.CrossRefPubMed Decramer M, Miravitlles M, Price D, Román-Rodríguez M, Llor C, Welte T, et al. New horizons in early stage COPD--improving knowledge, detection and treatment. Respir Med. 2011;105:1576–87.CrossRefPubMed
7.
go back to reference Kaplan A, Freeman D, Cleland J, Cerasoli F, Price D. Detecting mild COPD is not a waste of resources. Prim Care Respir J. 2011;20:238–9.CrossRefPubMed Kaplan A, Freeman D, Cleland J, Cerasoli F, Price D. Detecting mild COPD is not a waste of resources. Prim Care Respir J. 2011;20:238–9.CrossRefPubMed
10.
go back to reference Hansen JE, Sun X-G, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest. 2007;131:349–55.CrossRefPubMed Hansen JE, Sun X-G, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest. 2007;131:349–55.CrossRefPubMed
11.
go back to reference Schwarzer G. meta: an R package for meta-analysis. R News. 2007;7:40–5. Schwarzer G. meta: an R package for meta-analysis. R News. 2007;7:40–5.
12.
13.
go back to reference Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRef Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRef
15.
go back to reference Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs AP, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012;13:13.CrossRefPubMedPubMedCentral Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs AP, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012;13:13.CrossRefPubMedPubMedCentral
16.
go back to reference Moreira GL, Manzano BM, Gazzotti MR, Nascimento OA, Perez-Padilla R, Menezes AMB, et al. PLATINO, a nine-year follow-up study of COPD in the city of Sao Paulo, Brazil: the problem of underdiagnosis. J Bras Pneumol. 2014;40:30–7.CrossRefPubMedPubMedCentral Moreira GL, Manzano BM, Gazzotti MR, Nascimento OA, Perez-Padilla R, Menezes AMB, et al. PLATINO, a nine-year follow-up study of COPD in the city of Sao Paulo, Brazil: the problem of underdiagnosis. J Bras Pneumol. 2014;40:30–7.CrossRefPubMedPubMedCentral
17.
go back to reference Nascimento OA, Camelier A, Rosa FW, Menezes AMB, Perez-Padilla R, Jardim JR. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in Sao Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res. 2007;40:887–95.CrossRefPubMed Nascimento OA, Camelier A, Rosa FW, Menezes AMB, Perez-Padilla R, Jardim JR. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in Sao Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res. 2007;40:887–95.CrossRefPubMed
18.
go back to reference Talamo C, de Oca MM, Halbert R, Perez-Padilla R, Jardim JRB, Muino A, et al. Diagnostic labeling of COPD in five Latin American cities. Chest. 2007;131:60–7.CrossRefPubMed Talamo C, de Oca MM, Halbert R, Perez-Padilla R, Jardim JRB, Muino A, et al. Diagnostic labeling of COPD in five Latin American cities. Chest. 2007;131:60–7.CrossRefPubMed
19.
go back to reference Artyukhov IP, Arshukova IL, Dobretsova EA, Dugina TA, Shulmin AV, Demko IV. Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region. Russia J COPD. 2015;10:1781–6. Artyukhov IP, Arshukova IL, Dobretsova EA, Dugina TA, Shulmin AV, Demko IV. Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region. Russia J COPD. 2015;10:1781–6.
20.
go back to reference De Godoy I, Tanni SE, Coelho LS, Martin RdEeS, Parenti LC, Andrade LM, et al. Smoking cessation program as a tool for the early diagnosis of chronic obstructive pulmonary disease. J Bras Pneumol. 2007;33:282–6.CrossRef De Godoy I, Tanni SE, Coelho LS, Martin RdEeS, Parenti LC, Andrade LM, et al. Smoking cessation program as a tool for the early diagnosis of chronic obstructive pulmonary disease. J Bras Pneumol. 2007;33:282–6.CrossRef
21.
go back to reference Ancochea J, Miravitlles M, Garcia-Rio F, Munoz L, Sanchez G, Sobradillo V, et al. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol. 2013;49:223–9.CrossRefPubMed Ancochea J, Miravitlles M, Garcia-Rio F, Munoz L, Sanchez G, Sobradillo V, et al. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol. 2013;49:223–9.CrossRefPubMed
22.
go back to reference Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64:863–8.CrossRefPubMed Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64:863–8.CrossRefPubMed
23.
go back to reference Schirnhofer L, Lamprecht B, Firlei N, Kaiser B, Buist AS, Halbert RJ, et al. Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease. Respiration. 2011;81:476–82.CrossRefPubMed Schirnhofer L, Lamprecht B, Firlei N, Kaiser B, Buist AS, Halbert RJ, et al. Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease. Respiration. 2011;81:476–82.CrossRefPubMed
24.
go back to reference Hvidsten SC, Storesund L, Wentzel-Larsen T, Gulsvik A, Lehmann S. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population: undiagnosed COPD in a general population. Clin Respir J. 2010;4:13–21.CrossRefPubMed Hvidsten SC, Storesund L, Wentzel-Larsen T, Gulsvik A, Lehmann S. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population: undiagnosed COPD in a general population. Clin Respir J. 2010;4:13–21.CrossRefPubMed
25.
26.
go back to reference Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2:257–66.CrossRefPubMedPubMedCentral Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2:257–66.CrossRefPubMedPubMedCentral
27.
go back to reference de CAM de Queiroz MC, Moreira MAC, Rabahi MF. Underdiagnosis of COPD at primary health care clinics in the city of Aparecida de Goiania. Brazil J Bras Pneumol. 2012;38:692–9.CrossRefPubMed de CAM de Queiroz MC, Moreira MAC, Rabahi MF. Underdiagnosis of COPD at primary health care clinics in the city of Aparecida de Goiania. Brazil J Bras Pneumol. 2012;38:692–9.CrossRefPubMed
28.
go back to reference U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force reccomendation statement. Ann Intern Med. 2008;148:529–34.CrossRef U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force reccomendation statement. Ann Intern Med. 2008;148:529–34.CrossRef
29.
go back to reference Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182:673–8.CrossRefPubMedPubMedCentral Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182:673–8.CrossRefPubMedPubMedCentral
30.
go back to reference Labonté LE, Tan WC, Li PZ, Mancino P, Aaron SD, Benedetti A, et al. Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD study. Am J Respir Crit Care Med. 2016;194:285–98.CrossRefPubMed Labonté LE, Tan WC, Li PZ, Mancino P, Aaron SD, Benedetti A, et al. Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD study. Am J Respir Crit Care Med. 2016;194:285–98.CrossRefPubMed
31.
go back to reference Llordes M, Jaen A, Almagro P, Heredia JL, Morera J, Soriano JB, et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. J COPD. 2015;12:404–12.CrossRef Llordes M, Jaen A, Almagro P, Heredia JL, Morera J, Soriano JB, et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. J COPD. 2015;12:404–12.CrossRef
32.
go back to reference Mahishale V, Mahishale A, Angadi N, Metgudmath V, Eti A, Lolly M, et al. Screening for chronic obstructive pulmonary disease in elderly subjects with dyspnoea and/or reduced exercise tolerance - a hospital based cross sectional study. J Chest Dis Tuberc. 2015;64:567–71. Mahishale V, Mahishale A, Angadi N, Metgudmath V, Eti A, Lolly M, et al. Screening for chronic obstructive pulmonary disease in elderly subjects with dyspnoea and/or reduced exercise tolerance - a hospital based cross sectional study. J Chest Dis Tuberc. 2015;64:567–71.
33.
go back to reference Zhang J, Zhou J, Lin X, Wang Q, Bai C, Hong Q. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology. 2013;18:297–302.CrossRefPubMed Zhang J, Zhou J, Lin X, Wang Q, Bai C, Hong Q. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology. 2013;18:297–302.CrossRefPubMed
Metadata
Title
Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis
Authors
Kate M. Johnson
Stirling Bryan
Shahzad Ghanbarian
Don D. Sin
Mohsen Sadatsafavi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2018
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-018-0731-1

Other articles of this Issue 1/2018

Respiratory Research 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.